• Proactive MD Reports Third Transaction of 2026 

    On January 16, Proactive MD announced that it acquired undisclosed allergy specialist practices in Virginia. Terms were not disclosed.  Proactive MD is a value-based care provider dedicated to transforming healthcare for patients, employers and health plan partners through integrated solutions. Its integrated model offers centralized... Read More »
  • GSK Acquires Rapt Therapeutics For $2.2 Billion 

    In its first transaction of the year, GSK Plc, announced that it acquired Rapt Therapeutics, Inc. for $58 per share.  That price equates to an aggregate equity value of $2.2 billion, according to GSK, which added that the upfront investment net of cash acquired comes to $1.9 billion. Net of cash acquired, GSK’s estimated upfront investment... Read More »
  • Worldwide Clinical Trials to Acquire Catalyst Clinical Research

    Worldwide Clinical Trials, a global contract research organization (CRO), announced on January 20 that it will be acquiring Wilmington, North Carolina-headquartered Catalyst Clinical Research, LLC. Financial terms of the deal were not disclosed. Catalyst Clinical Research, LLC is a specialized CRO delivering customizable clinical research... Read More »
  • Most Active Physician Group Buyers of 2025

    The deal volume in the Physician Medical Group (PMG) sector was strong throughout 2025, totaling 521 transactions, surpassing the 506 reported in 2024. The subsectors with the most activity were dental (248 deals), eye care (34), dermatology (32) and orthopaedic (31).  The sector’s year-over-year stability is due to strong competition... Read More »
  • ACES Acquires Ally Pediatric Therapy

    ACES announced that it is bolstering its services in Arizona with the acquisition of Paradise Valley-based Ally Pediatric Therapy. Founded in 2017, Ally Pediatric Therapy is a leading provider of applied behavior analysis (ABA) therapy and speech-language therapy to children and young adults with autism and other childhood disorders. Ally... Read More »

eHealth Deals Remain Active in August

August proved to be another busy month for eHealth transactions. According to our Deal Search Online database, there were 18 acquisitions in the eHealth sector in July 2019, and 17 in August. The most popular targets this month were cloud-based and data-analytics providers. There were eight digital health transactions with that focus, including Water Street Healthcare Partners and JLL Partners’ acquisition of THREAD, a virtual research platform used by biopharma, contract research organizations, not-for-profit researchers and life science organizations to capture global clinical study data for clinical studies. Water Street and JLL will invest to further develop and expand... Read More »
PE Firms Exit North American Dental Group

PE Firms Exit North American Dental Group

Abry Partners and The Riverside Company are selling North American Dental Group (NADG), concluding a four-year investment in the dental service organization (DSO). NADG operates in the United States, and its network includes more than 200 dental practices in 11 states and 23 regional markets. The buyer is Jacobs Holding AG, a global professional investment group that supports the Jacobs Foundation, one of the world’s leading charitable foundations. No financial terms were disclosed. Jacobs Holding is no stranger to the dental market. The company already owns Colosseum Dental Group, a dental care provider, and the addition of NADG will create the first transatlantic dental group. NADG and... Read More »
Managed Care Company GoHealth Acquired by Centerbridge Partners

Managed Care Company GoHealth Acquired by Centerbridge Partners

Medicare Advantage programs and ancillaries are bringing in big bucks and new buyers. On August 19, Centerbridge Partners, L.P. announced its acquisition of GoHealth, LLC for a reported $1.4 billion from Norwest Equity Partners, the second-largest managed care deal in 2019, so far. The company is a leading provider of Medical Advantage products in the direct-to-consumer channel. Its platform combines technology, data science, and proprietary algorithms to match consumers with the best healthcare policy and carriers in the Medicare, Individual & Family and Small Group markets. Centerbridge and GoHealth broke off negotiations earlier in August over price, according to reports in... Read More »
Healthcare Staffing Firms in Steady Demand

Healthcare Staffing Firms in Steady Demand

As healthcare companies and providers across the industry wrestle with staffing shortages and retention, staffing firms are looking to fill some of the gaps, thus driving M&A activity. According to our Deal Search Online database, there have been nine acquisitions focused on healthcare staffing firms so far this year, and that number will most likely grow. If a price had been disclosed, Medical Solutions’ takeover of C&A Industries, Inc. this month would surely be among the largest deals in this segment. Medical Solutions, a portfolio company of TPG Growth, specializes in placing registered nurses in temporary travel assignments throughout the country. The... Read More »
Robotics Firm Acquired by Siemens Healthineers

Robotics Firm Acquired by Siemens Healthineers

After a nearly two-year hiatus, the diagnostic and therapeutic imaging giant Siemens Healthineers AG (XETRA: SHL.DE) has agreed to purchase Corindus Vascular Robotics, Inc. (NYSE: CVRS) for $1.1 billion, at a price of $4.28 per share. Corindus is a global leader in robotic-assisted vascular interventions. Its CorPath platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. On a trailing 12-month basis, Cordindus reported approximately $12.3 million in revenue. Siemens plans to combine its high-quality imaging, digital and artificial intelligence tools with Corindus’ precision robotics platform to improve treatment for... Read More »
CROs and CDMOs are Still Selling Fast

CROs and CDMOs are Still Selling Fast

This past week Permira, a global investment firm based in the United Kingdom, spent $2.4 billion for Cambrex Corporation (NYSE: CBM). Cambrex is a premier contract development and manufacturing organization (CDMO) in the small molecule space and provides drug substance, drug product and analytical services across the entire drug lifecycle. The $2.4 billion purchase price includes the company’s net debt, for 4.2x revenue and 16.3x EBITDA,  represents a 47.1% premium to Cambrex’s closing price of $40.78 on August 6. The target reported a number of its own acquisitions recently, making the CDMO a more attractive buy. Cambrex acquired Halo Pharma in 2018 and Avista Pharma Solutions... Read More »